Xin Lang Cai Jing·2025-08-08 04:37Core Insights - The report highlights the significant role of CFOs in listed companies, with the total salary scale for A-share CFOs reaching 4.27 billion yuan in 2024 [1] - The average annual salary for CFOs in the A-share biopharmaceutical sector is 1.0042 million yuan [1] Salary Distribution - The salary distribution among A-share biopharmaceutical CFOs shows that 13% earn below 500,000 yuan, 46% earn between 500,000 and 1 million yuan, 33% earn between 1 million and 2 million yuan, and 8% earn above 2 million yuan [1] - The top five highest-paid CFOs are from Kanghong Pharmaceutical, Junshi Biosciences-U, Shenzhou Cell, Tebao Bio, and Aopumai, with salaries of 3 million yuan, 2.0602 million yuan, 1.4297 million yuan, 1 million yuan, and 1 million yuan respectively [1] Age and Education Distribution - CFOs aged between 40 and 50 years constitute 54% of the market, while those over 50 years account for 38%, and those aged 40 and below represent 8% [1] - The educational background of CFOs shows that 8% have an associate degree, 50% hold a bachelor's degree, and 42% possess a master's degree [1] Salary Changes - Among CFOs with over two years of tenure, the largest salary decrease was observed for Xu Baohong from Junshi Biosciences-U, with a year-on-year decline of 24.66% [1] - The largest salary increase was recorded for Liu Liwen from Zhixiang Jintai-U, with a year-on-year increase of 35.91% [1]